BVF Inc’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-334,398
Closed -$9.07M 84
2021
Q3
$9.07M Sell
334,398
-474,312
-59% -$12M 0.35% 56
2021
Q2
$21M Sell
808,710
-380,790
-32% -$9.13M 0.79% 34
2021
Q1
$25.6M Buy
+1,189,500
New +$30M 0.96% 30
2020
Q4
Sell
-1,227,405
Closed -$18.1M 69
2020
Q3
$18.1M Sell
1,227,405
-66,996
-5% -$1.21M 0.99% 33
2020
Q2
$28.9M Sell
1,294,401
-395,836
-23% -$7.24M 1.78% 21
2020
Q1
$23.9M Buy
1,690,237
+750,672
+80% +$11.4M 2.23% 15
2019
Q4
$15.3M Buy
939,565
+585,747
+166% +$13.9M 1.16% 22
2019
Q3
$12.4M Buy
353,818
+148,553
+72% +$7.07M 1.3% 26
2019
Q2
$11.6M Sell
205,265
-15,000
-7% -$1.08M 1.26% 26
2019
Q1
$16.1M Hold
220,265
1.8% 20
2018
Q4
$14.1M Sell
220,265
-30,000
-12% -$2.23M 1.84% 17
2018
Q3
$25M Sell
250,265
-85,000
-25% -$7.05M 2.19% 17
2018
Q2
$23.8M Sell
335,265
-50,800
-13% -$4.26M 2.32% 15
2018
Q1
$40.2M Sell
386,065
-208,332
-35% -$23.5M 4.07% 10
2017
Q4
$59.9M Sell
594,397
-784,737
-57% -$57.8M 7.22% 2
2017
Q3
$48.2M Sell
1,379,134
-280,066
-17% -$7.55M 6.13% 4
2017
Q2
$39.7M Sell
1,659,200
-79,400
-5% -$2M 6.17% 4
2017
Q1
$48.2M Buy
+1,738,600
New +$40.5M 8.21% 4

Other funds holding ANAB

BVF Inc's ANAB Position: Q4 2021 in Review

BVF Inc sold out of AnaptysBio (ANAB) in Q4 2021, closing a stake of 334,398 shares — an estimated $9.07M sold.

BVF Inc first reported a position in ANAB in Q1 2017 and held it in 18 quarters. The position peaked at $59.9M in Q4 2017. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2021.

  • BVF Inc reported no remaining AnaptysBio position as of Q4 2021 after selling out during the quarter.
  • BVF Inc sold 334,398 AnaptysBio shares in Q4 2021, an estimated $9.07M.
  • BVF Inc first reported a position in AnaptysBio in Q1 2017 and held it in 18 quarters.
  • BVF Inc's AnaptysBio position peaked at $59.9M in Q4 2017.
  • 136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2021.

Based on BVF Inc's 13F filing for Q4 2021, filed 14 Feb 2022.